Navigation Links
AcelRx Pharmaceuticals Reports Third Quarter 2012 Financial Results
Date:11/6/2012

">www.acelrx.com.

Forward Looking Statements
This press release contains forward-looking statements, including, but not limited to, statements related to AcelRx Pharmaceuticals' financial viability, anticipated increases in research and development and general and administrative expenses, the sufficiency of funds to support its clinical trials and operations, timing of interim and final results of its clinical trials, planned or anticipated future clinical development of AcelRx Pharmaceuticals' product candidates, including the release ARX-01 top-line clinical trial data, the release and anticipated timing of additional ARX-01 clinical trial data, the anticipated timing for remaining clinical trials, and the therapeutic and commercial potential of AcelRx Pharmaceuticals' product candidates.  These forward-looking statements are based on AcelRx Pharmaceuticals' current expectations and inherently involve significant risks and uncertainties.  AcelRx Pharmaceuticals' actual results and the timing of events could differ materially from those anticipated in such forward-looking statements as a result of these risks and uncertainties, which include, without limitation, risks related to: AcelRx ability to raise additional funds to support its clinical trials and operations; the success, cost and timing of AcelRx Pharmaceuticals' product development activities and clinical trials, including timing, release and implications of interim or final results of the ARX-01 Phase 3 clinical trials;  the uncertain clinical development process, including the risk that planned clinical trials may not have an effective design, enroll a sufficient number of patients, or be completed on schedule, if at all; any delays or inability to obtain, regulatory approval of its product candidates; its ability to obtain adequate clinical supplies of the drug and device components of its product candidates; its ability to attract funding partners or collaborators with dev
'/>"/>

SOURCE AcelRx Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. AcelRx Pharmaceuticals Doses the First Patients in ARX-04 Phase 2 Clinical Study
2. AcelRx Pharmaceuticals to Hold Third Quarter 2012 Financial Results Conference Call and Webcast on November 6, 2012
3. AcelRx Pharmaceuticals Hires Mike A. Royal, M.D. as Chief, Clinical Affairs
4. AcelRx Pharmaceuticals to Present at the UBS Global Life Sciences Conference
5. AcelRx Pharmaceuticals Receives Fourth and Fifth U.S. Patents for Small-Volume Oral Transmucosal Dosage Forms
6. AcelRx Pharmaceuticals to Present at Three Upcoming Investor Conferences
7. AcelRx Pharmaceuticals Reports Second Quarter 2012 Financial Results
8. AcelRx Pharmaceuticals to Present at the Canaccord Genuity 32nd Annual Healthcare Conference
9. AcelRx Pharmaceuticals to Hold Second Quarter 2012 Financial Results Conference Call and Webcast on August 9, 2012
10. AcelRx Pharmaceuticals Receives Two Additional U.S. Patents for Small-Volume Oral Transmucosal Dosage Forms
11. AcelRx Pharmaceuticals, Inc. Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... , Aug. 27, 2014 An experimental drug designed ... a viable first treatment for anemia of inflammation, according to ... treatment published online today in Blood , ... (ASH).    Anemia is a condition that occurs ... not function properly. When an individual has anemia, the body ...
(Date:8/27/2014)... 27, 2014 Kewaunee Scientific Corporation (Nasdaq: ... increased its quarterly cash dividend by 9% to twelve ... share, beginning with the dividend payable on September 22, ... business on September 8, 2014. About ... Kewaunee Scientific Corporation is a recognized global leader in ...
(Date:8/27/2014)... and NINGBO, China , Aug. ... Ningbo Menovo Pharmaceutical Co., Ltd, ("Menovo") today announced they ... of generic pharmaceuticals, primarily targeting the United ... agreement, Amerigen and Menovo will jointly develop products for ... . Menovo will be responsible for manufacturing API ...
Breaking Medicine Technology:Drug Represents First Potential Treatment for Common Anemia 2Drug Represents First Potential Treatment for Common Anemia 3Amerigen Pharmaceuticals Limited and the Ningbo Menovo Pharmaceutical Co., Ltd, today announced they had entered into a collaboration agreement regarding the development of generic pharmaceuticals, primarily targeting the United States market 2
... announces that a new market research report is ... Test-Volume-Sales-Forecasts-and-Supplier-Shares-by-Country.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=In_Vitro_Diagnostic title=,The 2011 Prostatic Acid Phosphatase Testing Market: ... Test Volume, Sales Forecasts and Supplier Shares ... US, Europe, Japan ...
... /PRNewswire-Asia-FirstCall/ -- Dehaier Medical Systems Ltd. (Nasdaq: ... emerging leader in the development, assembly, marketing and sale ... today announced its financial results for the third quarter ... Third Quarter 2011 Financial Highlights   ...
Cached Medicine Technology:The 2011 Prostatic Acid Phosphatase Testing Market: US, Europe, Japan 2The 2011 Prostatic Acid Phosphatase Testing Market: US, Europe, Japan 3The 2011 Prostatic Acid Phosphatase Testing Market: US, Europe, Japan 4The 2011 Prostatic Acid Phosphatase Testing Market: US, Europe, Japan 5Dehaier Medical Announces Record Third Quarter 2011 Financial Results 2Dehaier Medical Announces Record Third Quarter 2011 Financial Results 3Dehaier Medical Announces Record Third Quarter 2011 Financial Results 4Dehaier Medical Announces Record Third Quarter 2011 Financial Results 5Dehaier Medical Announces Record Third Quarter 2011 Financial Results 6Dehaier Medical Announces Record Third Quarter 2011 Financial Results 7Dehaier Medical Announces Record Third Quarter 2011 Financial Results 8Dehaier Medical Announces Record Third Quarter 2011 Financial Results 9Dehaier Medical Announces Record Third Quarter 2011 Financial Results 10
(Date:8/27/2014)... (PRWEB) August 28, 2014 A St. ... Danis & Lowe reports that the C.R. Bard ... thousands of consolidated transvaginal mesh lawsuits, recently filed a ... #136 pertains to the pretrial discovery process, and more ... sensitive evidence. , Carey Danis & Lowe is a ...
(Date:8/27/2014)... (PRWEB) August 28, 2014 Recently, BambooIndustry.com, an ... items, has announced that new bamboo panels are ... now providing deep discounts for clients worldwide. All people that ... a discounted rate, from 10 to 30 percent off. ... the new panels. “At the moment, all our new and ...
(Date:8/27/2014)... West Palm Beach, Florida (PRWEB) August 28, 2014 ... star Kevin Harrington, Chairman of As Seen On ... also known as “The Millionaire Maker”. as Excelerate attendees ... real sharks, and will have the ability to pitch ... team of World Renowned Business Experts and Millionaire Mentors ...
(Date:8/27/2014)... (PRWEB) August 28, 2014 Delta, a ... recently added several practical Cat D7R Dozers to its ... company’s senior spokesman has announced that all these items ... this promotion is to expand Delta’s market share in ... proud to launch the special offer; he has much ...
(Date:8/27/2014)... August 27, 2014 Taking its popular obstacle ... Steele Creek YMCA will host its largest crowd at ... Saturday, September 13 at YMCA Camp Thunderbird . ... divisions: adult, youth and teams. Within each division, runners ... their physical limit - for a worthy cause. All ...
Breaking Medicine News(10 mins):Health News:Carey Danis & Lowe Reports On New Court Order in C.R. Bard Transvaginal Mesh MDL 2Health News:BambooIndustry.com: Cheap Bamboo Panels for Clients Worldwide Offered Online 2Health News:Reliable Supplier Delta Adds New Items To Its Used Bulldozer Collection 2Health News:C2 Survival Racers Go to Extremes to Provide Kids with YMCA Programs 2
... , , ... , ... , , , ... ...
... ... ... ... ...
... has studied the international research alliance the Multilateral Initiative ... general and the strengthening of research environments in Africa. ... in areas outside Africa. This has led to a ... problems that dominate everyday life in those areas where ...
... ... iTouch. The innovative torque application is the first of its kind. , ... San Diego, CA (PRWEB) February 22, 2010 -- Flexible Assembly ... iTouch. The innovative torque application is the first of its kind and is free for ...
... , ... Shield of Texas has designated Houston Northwest Medical Center as a Blue Distinction Center for ... Houston, TX ... Northwest Medical Center as a Blue Distinction Center for Spine Surgery. Blue Distinction Centers for ...
... ... ... ... ...
Cached Medicine News:Health News:Statewide Poll: Pennsylvania Must Adequately Fund Senior Care Services 2Health News:Statewide Poll: Pennsylvania Must Adequately Fund Senior Care Services 3Health News:Remuda Ranch Programs for Eating and Anxiety Disorders Sponsors a Special Edition of the Award-Winning Documentary America The Beautiful 2Health News:Remuda Ranch Programs for Eating and Anxiety Disorders Sponsors a Special Edition of the Award-Winning Documentary America The Beautiful 3Health News:Remuda Ranch Programs for Eating and Anxiety Disorders Sponsors a Special Edition of the Award-Winning Documentary America The Beautiful 4Health News:Remuda Ranch Programs for Eating and Anxiety Disorders Sponsors a Special Edition of the Award-Winning Documentary America The Beautiful 5Health News:Malaria research must be based in Africa 2Health News:Flexible Assembly Systems Announces New Torque Calculator App for the iPhone 2Health News:Houston Northwest Medical Center Has Been Designated as a Blue Distinction Center for Spine Surgery 2Health News:Houston Northwest Medical Center Has Been Designated as a Blue Distinction Center for Spine Surgery 3Health News:Houston Northwest Medical Center Has Been Designated as a Blue Distinction Center for Spine Surgery 4Health News:AppDynamics Announces General Availability of AppDynamics v2.0 2Health News:AppDynamics Announces General Availability of AppDynamics v2.0 3Health News:AppDynamics Announces General Availability of AppDynamics v2.0 4Health News:AppDynamics Announces General Availability of AppDynamics v2.0 5Health News:AppDynamics Announces General Availability of AppDynamics v2.0 6Health News:AppDynamics Announces General Availability of AppDynamics v2.0 7Health News:AppDynamics Announces General Availability of AppDynamics v2.0 8Health News:AppDynamics Announces General Availability of AppDynamics v2.0 9
... catheters are efficient, economical, eliminate the ... patient comfort during the test period., ... have been designed to use temperature ... room-temperature calibration. The temperature correction factors ...
... and its specifically designed reagents, allows ... same sample, multiple analytes. This unique ... of laboratories willing to simplify and ... routine, as well as to reduce ...
The safePICO is a prebarcoded arterial sampler that helps you ensure patient and caregiver safety. SafePICO is part of 1st automatic, the worlds first automatic blood gas analysis system....
... Rapid exchange thrombectomy never ... with tortuous anatomy in mind, ... cut shaft, soft tip and ... trackability, and pushability. Glide in ...
Medicine Products: